Objective: Lacunar strokes are a leading cause of cognitive impairment and vascular dementia. However, adequate characterization of cognitive impairment is lacking. The aim of this study was to estimate the prevalence and characterize the neuropsychological impairment in lacunar stroke patients. Methods: All English-speaking participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial (National Clinical Trial 00059306) underwent neuropsychological testing at baseline. Raw scores were converted to z scores using published norms. Those with impairment (z À1.5) in memory and/or nonmemory domains were classified as having mild cognitive impairment (MCI). Results: Among the 1,636 participants, average z scores on all tests were <0, with the largest deficits seen on tests of episodic memory (range of means, À0.65 to À0.92), verbal fluency (mean, À0.89), and motor dexterity (mean, À2.5). Forty-seven percent were classified as having MCI (36% amnestic, 37% amnestic multidomain, 28% nonamnestic). Of those with modified Rankin score 0-1 and Barthel score ¼ 100, 41% had MCI. Younger age (odds ratio [OR] per 10-year increase, 0.87), male sex (OR, 1.3), less education (OR, 0.13-0.66 for higher education levels compared to 0-4 years education), poststroke disability (OR, 1.4), and impaired activities of daily living (OR, 1.8) were independently associated with MCI. Interpretation: In this large, well-characterized cohort of lacunar stroke patients, MCI was present in nearly half, including many with minimal or no physical disabilities. Cognitive dysfunction in lacunar stroke patients may commonly be overlooked in clinical practice but may be as important as motor and sensory sequelae.
S mall subcortical strokes (S3s), also known as lacunar strokes, are a leading cause of cognitive impairment and dementia. [1] [2] [3] Based on diagnostic criteria for subcortical vascular dementia, 4 efforts have been devoted to defining the neuropsychological profile of mild cognitive impairment (MCI) associated with subcortical vascular features, 5 but no general consensus based on adequate empirical data has yet been established. 2 A recent statement from the American Stroke Association emphasizes the complex nature of the neurocognitive patterns associated with these states. 6 Neuropsychological studies of lacunar stroke patients have reliably shown performance impairments, but these have been challenging to integrate into the profile generally associated with subcortical ischemic disease, that is, impaired information-processing speed, attention, working memory, and executive and motor function. 2 Whereas some studies have described data consistent with such a profile, 7-9 others have reported equal or greater impairment in episodic memory and language.
clinically well-described group of participants of the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. 12 SPS3 is a randomized trial that enrolled patients with a recent S3 in North America, Latin America, and Spain. The trial was aimed to define interventions to prevent stroke recurrence, cognitive decline, and major vascular events in S3 patients. Here we report on the neuropsychological data collected at baseline for all Englishspeaking participants randomized at US and Canadian sites.
Subjects and Methods
The study group included all SPS3 participants enrolled at any of the 58 US or Canadian clinical centers who received neuropsychological testing (NPT) in English, and who reported English as their preferred spoken language, or if 2 languages were spoken at home, reported English as spoken >50% of the time. Eligibility for SPS3 has been described in detail elsewhere. 12 Briefly, eligible participants had a recent symptomatic S3 confirmed by magnetic resonance imaging (MRI) and no evidence of cortical stroke, cardioembolic disease, or amenable carotid stenosis. At study entry, between 2 weeks to 6 months after the qualifying stroke, NPT, Mini Mental State Examination (MMSE), 13 Barthel Activities of Daily Living Index, 14 and modified Rankin Scale (m-Rankin) 15 were administered.
Patients with significant cognitive impairment (MMSE !2 standard deviations [SD] below the mean for age and education, ie, an adjusted score 24, 16 generally accepted as the cutoff for mild dementia) or disability due to stroke (m-Rankin >4) were excluded. Utilizing clinical and MRI information, local investigators classified the location of the symptomatic S3 as anterior circulation (basal ganglia, internal capsule, corona radiata, or centrum semiovale), thalamus, or posterior circulation (midbrain, pons, medulla, or cerebellum). Participants were randomized in a 2 Â 2 factorial design to both an antiplatelet intervention (aspirin plus placebo vs aspirin plus clopidogrel) and to target levels of systolic blood pressure. Recruitment was completed in April 2011. The SPS3 trial was approved by the institutional review boards of all participating centers, and all patients provided written informed consent. The SPS3 NPT battery was selected to combine broad domain coverage with acceptable administration times. The Cognitive Assessment Screening Instrument (CASI), with a wider measurement range and more comprehensive coverage than the MMSE, was included for the assessment of global cognition. 17 NPT were included to assess episodic memory (Cali- 24 To separate the effect of upper extremity motor impairment on performance, data were reported separately for a subgroup of subjects defined as motor intact, that is, subjects without incoordination, weakness, or sensory deficits on upper extremity on neurological exam. Z scores were compared with the m-Rankin and Barthel index scores for concurrent validation of results. The relationship between the performance on the CASI and NPT z scores was explored with Pearson correlation coefficient. Participants were classified into NCI or MCI subtypes according to the described criteria, with scores considered normal if z > À1.5 and impaired if z À1.5. NPT domains were identified by exploratory principal component analysis (PCA) with varimax rotation on raw and standardized z scores with entry of all neuropsychological test variables with the exception of the CASI and GP scores (global cognition and noncognitive measures, respectively).
Distributions of test scores were tested for normality using Kolmogorov-Smirnov test and for a median different from 0 using the Wilcoxon signed rank test. Demographic, clinical, and functional characteristics, and test scores were compared by NP status (NCI and MCI subtypes) using analysis of variance and chi-square tests. Multivariate relationships of neuropsychological status (MCI vs NCI) with patient demographics; prestroke factors including vascular risk factors and prior S3; stroke-related factors including location of stroke, upper extremity motor/sensory loss or incoordination, Barthel index, and m-Rankin; and finally prestroke and stroke-related factors combined, were assessed with logistic regression models (likelihood ratio test). Statistical significance was accepted at the 0.01 level, and all tests were 2 sided. Statistical analyses were done using SPSS 19.0 and MedCalc 12.1.0.
Results
A total of 3,020 patients were randomized into SPS3. Of the 1,960 participants randomized in the USA and Canada, 1,636 of the 1,663 (98%) English-speaking subjects had NPT and formed the study sample (Fig) . The study group was younger, with fewer males, and more educated than non-English-speaking groups, with higher prevalence of hypertension and ischemic heart disease ( Table 1) . Median time from qualifying stroke to NPT for the study sample was 63 days, with 47% tested between 6 weeks and 3 months from the S3. Half of the S3s were located in anterior circulation, and the rest in thalamus, brainstem, and cerebellum. The proportions of right and left S3 were comparable. Eighty-five percent of the study sample scored at or above the 25th percentile adjusted for age and education on the MMSE and !95 on the Barthel index.
Neither raw test scores nor z scores were distributed normally (all p < 0.001; Table 2 ). Distributions for the CASI, CVLT, and Clox were negatively skewed, whereas those for the BD, COWA, and DS were positively skewed (data not shown). Performances on all tests were lower than expected for age, and where applicable, for education and gender, that is median z scores were significantly below 0 (all p < 0.001). The largest deficits were seen on the CVLT, COWA, and GP. On the CVLT, short-and long-delay recall scores were equally impaired, with median z scores ¼ À1.0. Recognition memory was less affected (median z score ¼ 0, mean z score ¼ À0.65). Verbal fluency on the COWA was similarly Age, mean yrs (SD) 63 (11) 63 (13) 62 (11) 61 (10) 65 (11 . Impaired coordination and/or upper extremity function accounted for a portion of these deficits. Median z scores on all tests except the CVLT and Clox were significantly lower (all p < 0.01) for compromised patients. Patients with intact motor function in upper extremities performed better than those with affected function on the CASI, BD, SS, GP, and Clox tests, but not importantly so on the motor-neutral CVLT, COWA, and DS.
CASI scores were significantly correlated with performance on each of the other tests. Correlation coefficients between 0.47 and 0.59 were observed between CASI z scores and z scores for the CVLT, BD, SS, COWA, and DS. Correlation coefficients for the CASI with GP and Clox were lower (range, 0.31-0.34). Correlation coefficients were comparable when only motorintact participants were included.
Higher education (any college vs 9-12 years vs 5-8 years vs 0-4 years) was significantly associated (all p < 0.001) with higher z scores, regardless of whether norms were adjusted for education (CASI, COWA; data not shown). When participants with 0 to 4 years (n ¼ 32) and 5 to 8 years (n ¼ 83) of education were excluded from this analysis, those with any college averaged higher z scores when compared to those with 9 to 12 years of education (all p 0.002 except the CASI, p ¼ 0.02). When only motor-intact participants with at least 9 to 12 years or any college education were analyzed, those with any college averaged higher z scores (all p 0.006) for all except the CASI (p ¼ 0.2) and GP (p ! 0.03).
Higher m-Rankin scores and lower Barthel index scores were associated with increasing cognitive impairment (Supplementary Table 3 ). Of note, among participants with m-Rankin ratings of 0, there were still substantial performance impairments on CVLT, COWA, Clox, and GP. Participants with a Barthel index score <95 had significantly lower z scores for all tests except the COWA (p ¼ 0.04) and Clox (p ¼ 0.4).
PCA, with specification of 3 factors, accounted for 73% of the variance (Supplementary Table 4 ). The first factor included episodic memory measures (CVLT), the second measures of perceptual and verbal processing speed (BD, SS, COWA, DS), and the third the Clox, which measures aspects of executive functioning. Based on these results, criteria for classification of NP status were refined: memory domain impairment ¼ definite impairment (z À1.5) on at least 2 CVLT measures; perceptual-verbal processing speed domain impairment ¼ definite impairment (z À1.5) on at least 2 tests among the BD, SS, COWA, and DS; and executive functioning domain impairment ¼ definite impairment (z À1.5) on the Clox. NCI classification was assigned if there was no domain impairment; MCIa if there was only memory domain impairment; MCImd if, in addition to memory, there was perceptual-verbal processing speed and/or executive functioning domain impairment; and MCIna if there was only perceptual-verbal processing speed and/or executive functioning domain impairment. Fifty-three percent of participants were classified as NCI, and 47% met criteria for MCI, with roughly equal numbers for MCIa, MCImd, and MCIna (Table 3) .
Participants with MCI had lower education than those with NCI (57% vs 37% 12 yrs, p < 0.001), and were more likely to have diabetes (40% vs 32%, p ¼ 0.001), a prior S3 (13% vs 8%, p ¼ 0.002), and a more severe qualifying stroke (41% vs 26% m-Rankin !2, p < 0.001). However, of the 872 participants with at least some college education, 37% had MCI, and of the 952 participants with no significant disability (Rankin ¼ 0-1 and Barthel index ¼ 100), 41% had MCI. Participants with MCI performed more poorly on measures of global cognition including CASI and MMSE. Overall, those with memory impairment (MCIa or MCImd) were similar to those without memory impairment, except they were less educated (p < 0.001) and more likely to have had a prior S3 (p < 0.001) and a more severe qualifying stroke (p < 0.001; see Table 3 ). Participants with MCImd had the highest levels of functional and cognitive impairment among all MCI subtypes (see Table 3 ).
Younger age, male sex, and less education were independently associated with a higher likelihood of MCI (Table 4) . Among prestroke factors, only prior S3 contributed to a higher likelihood of MCI, whereas among stroke-related factors, Barthel <95 and m-Rankin >0 each did so independently. When prestroke and strokerelated factors were combined, only Barthel <95 and m-Rankin >0 remained in the model. Vascular risk factors, location and lateralization of index stroke, and upper extremity motor or sensory loss or incoordination did not add information about likelihood of MCI. 
Discussion
In this study, we evaluated the severity and pattern of performance deficits on NPT in a large cohort of 1,636 US and Canadian English-speaking subjects with symptomatic, MRI-confirmed S3 enrolled in the SPS3 trial. On average, participants presented modest to substantial impairments compared to normative data. The majority of deficits remained when those with upper extremity weakness, incoordination, and/or sensory loss were excluded. Deficits were particularly prominent on tests of verbal episodic memory, verbal fluency, clock drawing, and motor dexterity, and validated by clinical measures of global cognition (CASI), disability (m-Rankin), and activities of daily living (ADLs; Barthel). Half of the cohort met psychometric criteria for MCI, with amnestic deficits as prevalent as nonamnestic. MCI was associated with younger age, male sex, less education, poststroke disability, and impaired ADLs. Our finding of impaired processing speed, motor dexterity, and executive functioning is consistent with the impairment pattern hypothesized for subcortical ischemic disease 2 and with neuropsychological studies on S3 populations. 8, 10, 11, 25 However, our findings of equally prominent episodic memory deficits in S3 subjects do not readily fit this pattern. Reports of episodic memory impairment have been sparse to date, 5, 8, 11, 25, 26 and incident lacunes have been reported to impact processing speed and motor control but not memory. 27 Discrepancies may be due to differences in the time lag between stroke and NPT, in the type of memory assessments, and 29 was not associated with a higher likelihood of MCI in our data. In addition, the pattern of episodic memory impairment, with impaired delayed recall but relatively spared recognition, suggests disruption of prefrontal cortex-based strategic retrieval rather than hippocampus-based associative processes 30 expected in the presence of AD.
Estimates of MCI prevalence in S3 populations vary considerably. We found that 47% of our subjects met MCI criteria. Estimates from other studies of similar populations have ranged from 7 to 75%. 25, 31 In general population-based studies, the prevalence of different definitions of MCI ranges from 16 to 23% in individuals aged 65 years or older. 32 Discrepancies are likely due to MCI definitions. Our definition is based on post hoc application of psychometric criteria, and the resulting prevalence estimate of MCI must be weighed against the expected proportion scoring below the cutoff in normal populations ($7%). MCI classifications similar to ours have served as a basis for prevalence estimates in epidemiological studies. 33, 34 As per the recent AHA/ASA criteria for vascular MCI, 6 we have applied a 1.5 SD below normal cutoff and determined the independence of cognitive from motor/sensory deficits. We have imaging evidence of cerebrovascular disease, albeit without a clear temporal relationship between the S3 and MCI. We have insufficient information to firmly establish a decline from prestroke functioning, and the preservation of instrumental ADLs. We cannot rule out that a proportion of our subjects with MCI may have already been cognitively impaired prior to study entry as a result of clinically silent small vessel disease, vascular risk factors, or a nonvascular neurodegenerative disorder. However, we failed to find an association between vascular risk factors and risk of MCI. Subjects with an age-and educationadjusted MMSE score <24 were excluded from the SPS3 trial.
12
On these grounds, we suggest that MCI, identified in half of our participants, is an important clinical sequela of lacunar stroke, more prevalent than physical disability defined by m-Rankin score !2 (33%), and present in 41% of patients with no significant disability (m-Rankin ¼ 0-1, Barthel index ¼ 100). We observed cognitive deficits on the order of z ¼ À0.4 to À0.8 in participants with no significant physical limitations. It should be noted that these subjects may have functional limitations not captured by the m-Rankin and Barthel ratings. We speculate that the cognitive effects of lacunar stroke are at least as important as disability related to motor or sensory deficits, and occur in their absence, particularly in younger patients. The association between young age and cognitive impact of lacunar stroke is not readily explainable and could be an artifact due to limitations in normative data for older adults including a larger variability.
The strengths of our study are a large, well-characterized sample of patients with MRI-confirmed small subcortical stroke likely resulting from cerebral small vessel disease, and broad coverage provided by our NPT battery. We recognize limitations in the generalizability of our findings. There may be a selection bias toward lesser stroke severity in our SPS3 trial participants, with underestimation of the true impact on cognition. The findings may be specific to US and Canadian English-speaking subjects. Another limitation is our use of different sets of normative data for comparative purposes. These normative data have been developed on different populations, some on small study samples, and are not adjusted consistently for age, sex, and education. Our findings may be, at least in part, due to having used different norms for tests of episodic memory, processing speed, and motor and executive function. However, the consistent relationships of our norm-based NPT scores with CASI, m-Rankin, and Barthel support their validity. Future studies will benefit not only from a harmonized approach to poststroke neuropsychological assessment but also from properly stratified norms from a populationbased sample of healthy subjects.
In summary, this study has shown significant cognitive impairments following lacunar strokes. It has provided empirical confirmation of impairments in processing speed, motor dexterity, and executive function, conceptually linked to subcortical ischemic disease, and drawn attention to episodic memory impairment as an equally central feature. Our findings have implications for clinical practice where cognitive dysfunction in lacunar stroke patients may be as common and as important as motor and sensory sequelae, but overlooked.
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